73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many
Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p
New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO
New, revised topics released in ACR appropriateness criteria

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c
How a little-known glycoprotein blocks a cancer cell's immune response

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child
Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors
New bone cancer drug improves survival rates by 50% in preclinical trials

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer
Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas
Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en
Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in
Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha